Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both?

Podobne knjige/članki

• A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
  od: Bujalska, I J, et al.
  Izdano: (2008)
• Lack of Significant Metabolic Abnormalities in Mice with Liver-Specific Disruption of 11β-Hydroxysteroid Dehydrogenase Type 1
  od: Lavery, Gareth G., et al.
  Izdano: (2012)
• 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome
  od: Bailey, Matthew A.
  Izdano: (2017)
• Characterisation of 11β-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat
  od: Bujalska, Iwona J, et al.
  Izdano: (2007)
• Weight loss increases 11β-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue
  od: Tomlinson, Jeremy W., et al.
  Izdano: (2004)